Novel conformationally extended naphthalene-based inhibitors of farnesyltransferase

被引：28

作者：

Burns, CJ ^{[1
]}

Guitton, JD ^{[1
]}

Baudoin, B ^{[1
]}

Lelievre, Y ^{[1
]}

Duchesne, M ^{[1
]}

Parker, F ^{[1
]}

Fromage, N ^{[1
]}

Commercon, A ^{[1
]}

机构：

[1] RHONE POULENC RORER SA,CTR RECH VITRY ALFORTVILLE,F-94403 VITRY SUR SEINE,FRANCE

来源：

JOURNAL OF MEDICINAL CHEMISTRY | 1997年 / 40卷 / 12期

关键词：

D O I：

10.1021/jm9701177

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1763 / 1767

页数：5

共 34 条

[11] BENZODIAZEPINE PEPTIDOMIMETICS - POTENT INHIBITORS OF RAS FARNESYLATION IN ANIMAL-CELLS
JAMES, GL
GOLDSTEIN, JL
BROWN, MS
RAWSON, TE
SOMERS, TC
MCDOWELL, RS
CROWLEY, CW
LUCAS, BK
LEVINSON, AD
MARSTERS, JC
[J]. SCIENCE, 1993, 260 (5116) : 1937 - 1942
[12] POLYLYSINE AND CVIM SEQUENCES OF K-RASB DICTATE SPECIFICITY OF PRENYLATION AND CONFER RESISTANCE TO BENZODIAZEPINE PEPTIDOMIMETIC IN-VITRO
JAMES, GL
GOLDSTEIN, JL
BROWN, MS
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) : 6221 - 6226
[13] ISOPRENOID ADDITION TO RAS PROTEIN IS THE CRITICAL MODIFICATION FOR ITS MEMBRANE ASSOCIATION AND TRANSFORMING ACTIVITY
KATO, K
COX, AD
HISAKA, MM
GRAHAM, SM
BUSS, JE
DER, CJ
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (14) : 6403 - 6407
[14] KOBLAN KS, 1995, PROTEIN SCI, V4, P681
[15] PROTEIN FARNESYLTRANSFERASE INHIBITORS BLOCK THE GROWTH OF RAS-DEPENDENT TUMORS IN NUDE-MICE
KOHL, NE
WILSON, FR
MOSSER, SD
GIULIANI, E
DESOLMS, SJ
CONNER, MW
ANTHONY, NJ
HOLTZ, WJ
GOMEZ, RP
LEE, TJ
SMITH, RL
GRAHAM, SL
HARTMAN, GD
GIBBS, JB
OLIFF, A
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (19) : 9141 - 9145
[16] SELECTIVE-INHIBITION OF RAS-DEPENDENT TRANSFORMATION BY A FARNESYLTRANSFERASE INHIBITOR
KOHL, NE
MOSSER, SD
DESOLMS, SJ
GIULIANI, EA
POMPLIANO, DL
GRAHAM, SL
SMITH, RL
SCOLNICK, EM
OLIFF, A
GIBBS, JB
[J]. SCIENCE, 1993, 260 (5116) : 1934 - 1937
[17] Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity
Leftheris, K
Kline, T
Vite, GD
Cho, YH
Bhide, RS
Patel, DV
Patel, MM
Schmidt, RJ
Weller, HN
Andahazy, ML
Carboni, JM
GulloBrown, JL
Lee, FYF
Ricca, C
Rose, WC
Yan, N
Barbacid, M
Hunt, JT
Meyers, CA
Seizinger, BR
Zahler, R
Manne, V
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (01) : 224 - 236
[18] PEPTIDE-BASED P21(RAS) FARNESYL TRANSFERASE INHIBITORS - SYSTEMATIC MODIFICATION OF THE TETRAPEPTIDE CA(1)A(2)X MOTIF
LEFTHERIS, K
KLINE, T
NATARAJAN, S
DEVIRGILIO, MK
CHO, YH
PLUSCEC, J
RICCA, C
ROBINSON, S
SEIZINGER, BR
MANNE, V
MEYERS, CA
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (07) : 887 - 892
[19] RAS CAAX PEPTIDOMIMETIC FTI-277 SELECTIVELY BLOCKS ONCOGENIC RAS SIGNALING BY INDUCING CYTOPLASMIC ACCUMULATION OF INACTIVE RAS-RAF COMPLEXES
LERNER, EC
QIAN, YM
BLASKOVICH, MA
FOSSUM, RD
VOGT, A
SUN, JZ
COX, AD
DER, CJ
HAMILTON, AD
SEBTI, SM
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) : 26802 - 26806
[20] DISRUPTION OF ONCOGENIC K-RAS4B PROCESSING AND SIGNALING BY A POTENT GERANYLGERANYLTRANSFERASE-I INHIBITOR
LERNER, EC
QIAN, YM
HAMILTON, AD
SEBTI, SM
[J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (45) : 26770 - 26773

← 1 2 3 4 →